| Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains … BP Howden, JK Davies, PDR Johnson, TP Stinear, ML Grayson Clinical microbiology reviews 23 (1), 99-139, 2010 | 1094 | 2010 |
| Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility BP Howden, PB Ward, PGP Charles, TM Korman, A Fuller, P Du Cros, ... Clinical Infectious Diseases 38 (4), 521-528, 2004 | 569 | 2004 |
| Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin-Intermediate Staphylococcus aureus PGP Charles, PB Ward, PDR Johnson, BP Howden, ML Grayson Clinical infectious diseases 38 (3), 448-451, 2004 | 454 | 2004 |
| Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR BP Howden, CRE McEvoy, DL Allen, K Chua, W Gao, PF Harrison, J Bell, ... PLoS pathogens 7 (11), e1002359, 2011 | 295 | 2011 |
| Whole genome sequencing in clinical and public health microbiology JC Kwong, N McCallum, V Sintchenko, BP Howden Pathology 47 (3), 199-210, 2015 | 282 | 2015 |
| Isolation and rapid sharing of the 2019 novel coronavirus (SARS‐CoV‐2) from the first patient diagnosed with COVID‐19 in Australia L Caly, J Druce, J Roberts, K Bond, T Tran, R Kostecki, Y Yoga, ... Medical Journal of Australia 212 (10), 459-462, 2020 | 262 | 2020 |
| Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ... Journal of Infectious Diseases 204 (3), 340-347, 2011 | 259 | 2011 |
| Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia BP Howden, PDR Johnson, PB Ward, TP Stinear, JK Davies Antimicrobial Agents and Chemotherapy 50 (9), 3039-3047, 2006 | 254 | 2006 |
| Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand JD Turnidge, D Kotsanas, W Munckhof, S Roberts, CM Bennett, ... Medical Journal of Australia 191 (7), 368-373, 2009 | 246 | 2009 |
| Two Novel Point Mutations in Clinical Staphylococcus aureus Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection W Gao, K Chua, JK Davies, HJ Newton, T Seemann, PF Harrison, ... PLoS pathogens 6 (6), e1000944, 2010 | 221 | 2010 |
| Current and emerging topical antibacterials and antiseptics: agents, action, and resistance patterns DA Williamson, GP Carter, BP Howden Clinical microbiology reviews 30 (3), 827-860, 2017 | 220 | 2017 |
| Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine BP Howden, MA Slavin, AP Schwarer, AM Mijch European Journal of Clinical Microbiology and Infectious Diseases 22 (2 …, 2003 | 214 | 2003 |
| Dumb and Dumber—The Potential Waste of a Useful Antistaphylococcal Agent: Emerging Fusidic Acid Resistance in Staphylococcus aureus BP Howden, ML Grayson Clinical Infectious Diseases 42 (3), 394-400, 2006 | 208 | 2006 |
| Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ... Antimicrobial agents and chemotherapy 57 (4), 1654-1663, 2013 | 204 | 2013 |
| In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae A Poudyal, BP Howden, JM Bell, W Gao, RJ Owen, JD Turnidge, ... Journal of Antimicrobial Chemotherapy 62 (6), 1311-1318, 2008 | 201 | 2008 |
| Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study KS Baker, TJ Dallman, PM Ashton, M Day, G Hughes, PD Crook, ... The Lancet infectious diseases 15 (8), 913-921, 2015 | 193 | 2015 |
| Prospective whole-genome sequencing enhances national surveillance of Listeria monocytogenes JC Kwong, K Mercoulia, T Tomita, M Easton, HY Li, DM Bulach, ... Journal of clinical microbiology 54 (2), 333-342, 2016 | 189 | 2016 |
| Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients E Bishop, S Melvani, BP Howden, PGP Charles, ML Grayson Antimicrobial agents and chemotherapy 50 (4), 1599-1602, 2006 | 188 | 2006 |
| Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis JYH Lee, IR Monk, A Gonçalves da Silva, T Seemann, KYL Chua, ... Nature microbiology 3 (10), 1175-1185, 2018 | 159 | 2018 |
| Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA-its evolving antimicrobial … K Chua, F Laurent, G Coombs, ML Grayson, BP Howden Clinical infectious diseases: an official publication of the Infectious …, 2011 | 159 | 2011 |
Tim StinearProfessor, University of MelbourneVerified email at unimelb.edu.au
